In 2024, the Center for Drug Evaluation of the National Medical Products Administration (NMPA) in China received *** New Drug Applications (NDA) for innovative drugs. Most NDA applications were concerning innovative chemical drugs or biopharmaceuticals, with only ** innovative Traditional Chinese Medicine (TCM) NDA applications submitted in 2024. A New Drug Application (NDA) is the mechanism through which pharmaceutical manufacturers propose that the regulatory body approve a new drug or biopharmaceutical for general use and sale.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
National Medical Products Administration. (March 18, 2025). Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2024, by drug type [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 05, 2026, from /statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. "Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2024, by drug type." Chart. March 18, 2025. ÌÇÐÄÆƽâ°æ. Accessed August 05, 2026. /statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. (2025). Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2024, by drug type. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 05, 2026. /statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration. "Number of New Drug Applications (Nda) for Innovative Drugs Submitted in China from 2018 to 2024, by Drug Type." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Mar 2025, /statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
National Medical Products Administration, Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2024, by drug type ÌÇÐÄÆƽâ°æ, /statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/ (last visited August 05, 2026)
Number of New Drug Applications (NDA) for innovative drugs submitted in China from 2018 to 2024, by drug type [Graph], National Medical Products Administration, March 18, 2025. [Online]. Available: /statistics/1319952/china-number-of-new-drug-applications-of-innovative-drugs-submitted/
